Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes (Q38926063)

7 September 2017

title

Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes (English)

1 reference

Erratum: Corrigendum: Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes

7 September 2017

corrigendum / erratum

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/NCOMMS8280

7

Zoltán Kutalik

1 reference

7 September 2017

Rosanna Santoro

16

0 references

Stephanie Bibert

Stephanie Bibert

2

0 references

Rune Hartmann

Rune Hartmann

22

0 references

Pierre-Yves Bochud

Pierre-Yves Bochud

21

0 references

Markus H Heim

Markus H Heim

20

0 references

Darius Moradpour

Darius Moradpour

13

0 references

author name string

Ewa Terczyńska-Dyla

1

1 reference

7 September 2017

Francois H T Duong

3

1 reference

7 September 2017

Ilona Krol

4

1 reference

7 September 2017

Sanne Jørgensen

5

1 reference

7 September 2017

Emilie Collinet

6

1 reference

7 September 2017

Vincent Aubert

8

1 reference

7 September 2017

Andreas Cerny

9

1 reference

7 September 2017

Laurent Kaiser

10

1 reference

7 September 2017

Raffaele Malinverni

11

1 reference

7 September 2017

Alessandra Mangia

12

1 reference

7 September 2017

Beat Müllhaupt

14

1 reference

7 September 2017

Francesco Negro

15

1 reference

7 September 2017

David Semela

17

1 reference

7 September 2017

Nasser Semmo

18

1 reference

7 September 2017

Swiss Hepatitis C Cohort Study Group

19

1 reference

7 September 2017

language of work or name

English

0 references

publication date

23 December 2014

1 reference

7 September 2017

published in

Nature Communications

1 reference

7 September 2017

volume

5

1 reference

7 September 2017

page(s)

5699

1 reference

Global epidemiology of hepatitis C virus infection

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Interferon signaling and treatment outcome in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Interferon- Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Crystal Structure of Human Interferon-λ1 in Complex with Its High-Affinity Receptor Interferon-λR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Acute hepatitis C: current status and remaining challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Nonsynonymous variant Pro70Ser (rs117648444) in IFNL4 gene identifies carriers of the rs368234815 ΔG allele with higher HCV RNA decline during the first 4 weeks of pegylated interferon and ribavirin therapy in HCV-1 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Will IL28B polymorphisms remain relevant to direct-acting antiviral treatment paradigms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Does IL28B genotyping still have a role in the era of direct-acting antiviral therapy for chronic hepatitis C infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

IL28B in the era of direct-acting antivirals for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Faldaprevir and deleobuvir for HCV genotype 1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

IFNL4-ΔG genotype is associated with slower viral clearance in hepatitis C, genotype-1 patients treated with sofosbuvir and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Human interferon-lambda3 is a potent member of the type III interferon family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

Cohort Profile: the Swiss Hepatitis C Cohort Study (SCCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6699

21 January 2018

Identifiers

DOI

10.1038/NCOMMS6699

1 reference

Dimensions Publication ID

7 September 2017

0 references

1046215656

0 references

1 reference